[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Eye Drops (Artificial Tear) Market Growth 2022-2028

December 2022 | 109 pages | ID: G874ED1E2BB6EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Lubricant eye drops used to treat the dryness and irritation associated with deficient tear production in keratoconjunctivitis sicca (dry eyes). They are also used to moisten contact lenses and in eye examinations.

The global market for Eye Drops (Artificial Tear) is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Eye Drops (Artificial Tear) market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Eye Drops (Artificial Tear) market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Eye Drops (Artificial Tear) market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Eye Drops (Artificial Tear) market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Eye Drops (Artificial Tear) players cover Allergan, Alcon, Novartis, Santen Pharma and Johnson & Johnson, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage

This latest report provides a deep insight into the global Eye Drops (Artificial Tear) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Eye Drops (Artificial Tear) market, with both quantitative and qualitative data, to help readers understand how the Eye Drops (Artificial Tear) market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Tons.

Market Segmentation:

The study segments the Eye Drops (Artificial Tear) market and forecasts the market size by Type (Allergy Eye Care and Standard Eye Care,), by Application (Pharmacy, Internet, Grocery and Optical Chains), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
  • Allergy Eye Care
  • Standard Eye Care
Segmentation by application
  • Pharmacy
  • Internet
  • Grocery
  • Optical Chains
Segmentation by region
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
Major companies covered
  • Allergan
  • Alcon
  • Novartis
  • Santen Pharma
  • Johnson & Johnson
  • Bausch & Lomb
  • Thea pharmaceuticals
  • URSAPHARM
  • SIMILASAN
  • Akorn
  • United Laboratories
  • Sun Pharmaceutical
  • Jianfeng Group
Chapter Introduction

Chapter 1: Scope of Eye Drops (Artificial Tear), Research Methodology, etc.

Chapter 2: Executive Summary, global Eye Drops (Artificial Tear) market size (sales and revenue) and CAGR, Eye Drops (Artificial Tear) market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.

Chapter 3: Eye Drops (Artificial Tear) sales, revenue, average price, global market share, and industry ranking by company, 2017-2022

Chapter 4: Global Eye Drops (Artificial Tear) sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.

Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.

Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace

Chapter 10: Manufacturing cost structure analysis

Chapter 11: Sales channel, distributors, and customers

Chapter 12: Global Eye Drops (Artificial Tear) market size forecast by region, by country, by type, and application.

Chapter 13: Comprehensive company profiles of the leading players, including Allergan, Alcon, Novartis, Santen Pharma, Johnson & Johnson, Bausch & Lomb, Thea pharmaceuticals, URSAPHARM and SIMILASAN, etc.

Chapter 14: Research Findings and Conclusion
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Eye Drops (Artificial Tear) Annual Sales 2017-2028
  2.1.2 World Current & Future Analysis for Eye Drops (Artificial Tear) by Geographic Region, 2017, 2022 & 2028
  2.1.3 World Current & Future Analysis for Eye Drops (Artificial Tear) by Country/Region, 2017, 2022 & 2028
2.2 Eye Drops (Artificial Tear) Segment by Type
  2.2.1 Allergy Eye Care
  2.2.2 Standard Eye Care
2.3 Eye Drops (Artificial Tear) Sales by Type
  2.3.1 Global Eye Drops (Artificial Tear) Sales Market Share by Type (2017-2022)
  2.3.2 Global Eye Drops (Artificial Tear) Revenue and Market Share by Type (2017-2022)
  2.3.3 Global Eye Drops (Artificial Tear) Sale Price by Type (2017-2022)
2.4 Eye Drops (Artificial Tear) Segment by Application
  2.4.1 Pharmacy
  2.4.2 Internet
  2.4.3 Grocery
  2.4.4 Optical Chains
2.5 Eye Drops (Artificial Tear) Sales by Application
  2.5.1 Global Eye Drops (Artificial Tear) Sale Market Share by Application (2017-2022)
  2.5.2 Global Eye Drops (Artificial Tear) Revenue and Market Share by Application (2017-2022)
  2.5.3 Global Eye Drops (Artificial Tear) Sale Price by Application (2017-2022)

3 GLOBAL EYE DROPS (ARTIFICIAL TEAR) BY COMPANY

3.1 Global Eye Drops (Artificial Tear) Breakdown Data by Company
  3.1.1 Global Eye Drops (Artificial Tear) Annual Sales by Company (2020-2022)
  3.1.2 Global Eye Drops (Artificial Tear) Sales Market Share by Company (2020-2022)
3.2 Global Eye Drops (Artificial Tear) Annual Revenue by Company (2020-2022)
  3.2.1 Global Eye Drops (Artificial Tear) Revenue by Company (2020-2022)
  3.2.2 Global Eye Drops (Artificial Tear) Revenue Market Share by Company (2020-2022)
3.3 Global Eye Drops (Artificial Tear) Sale Price by Company
3.4 Key Manufacturers Eye Drops (Artificial Tear) Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Eye Drops (Artificial Tear) Product Location Distribution
  3.4.2 Players Eye Drops (Artificial Tear) Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR EYE DROPS (ARTIFICIAL TEAR) BY GEOGRAPHIC REGION

4.1 World Historic Eye Drops (Artificial Tear) Market Size by Geographic Region (2017-2022)
  4.1.1 Global Eye Drops (Artificial Tear) Annual Sales by Geographic Region (2017-2022)
  4.1.2 Global Eye Drops (Artificial Tear) Annual Revenue by Geographic Region
4.2 World Historic Eye Drops (Artificial Tear) Market Size by Country/Region (2017-2022)
  4.2.1 Global Eye Drops (Artificial Tear) Annual Sales by Country/Region (2017-2022)
  4.2.2 Global Eye Drops (Artificial Tear) Annual Revenue by Country/Region
4.3 Americas Eye Drops (Artificial Tear) Sales Growth
4.4 APAC Eye Drops (Artificial Tear) Sales Growth
4.5 Europe Eye Drops (Artificial Tear) Sales Growth
4.6 Middle East & Africa Eye Drops (Artificial Tear) Sales Growth

5 AMERICAS

5.1 Americas Eye Drops (Artificial Tear) Sales by Country
  5.1.1 Americas Eye Drops (Artificial Tear) Sales by Country (2017-2022)
  5.1.2 Americas Eye Drops (Artificial Tear) Revenue by Country (2017-2022)
5.2 Americas Eye Drops (Artificial Tear) Sales by Type
5.3 Americas Eye Drops (Artificial Tear) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Eye Drops (Artificial Tear) Sales by Region
  6.1.1 APAC Eye Drops (Artificial Tear) Sales by Region (2017-2022)
  6.1.2 APAC Eye Drops (Artificial Tear) Revenue by Region (2017-2022)
6.2 APAC Eye Drops (Artificial Tear) Sales by Type
6.3 APAC Eye Drops (Artificial Tear) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Eye Drops (Artificial Tear) by Country
  7.1.1 Europe Eye Drops (Artificial Tear) Sales by Country (2017-2022)
  7.1.2 Europe Eye Drops (Artificial Tear) Revenue by Country (2017-2022)
7.2 Europe Eye Drops (Artificial Tear) Sales by Type
7.3 Europe Eye Drops (Artificial Tear) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Eye Drops (Artificial Tear) by Country
  8.1.1 Middle East & Africa Eye Drops (Artificial Tear) Sales by Country (2017-2022)
  8.1.2 Middle East & Africa Eye Drops (Artificial Tear) Revenue by Country (2017-2022)
8.2 Middle East & Africa Eye Drops (Artificial Tear) Sales by Type
8.3 Middle East & Africa Eye Drops (Artificial Tear) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Eye Drops (Artificial Tear)
10.3 Manufacturing Process Analysis of Eye Drops (Artificial Tear)
10.4 Industry Chain Structure of Eye Drops (Artificial Tear)

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Eye Drops (Artificial Tear) Distributors
11.3 Eye Drops (Artificial Tear) Customer

12 WORLD FORECAST REVIEW FOR EYE DROPS (ARTIFICIAL TEAR) BY GEOGRAPHIC REGION

12.1 Global Eye Drops (Artificial Tear) Market Size Forecast by Region
  12.1.1 Global Eye Drops (Artificial Tear) Forecast by Region (2023-2028)
  12.1.2 Global Eye Drops (Artificial Tear) Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Eye Drops (Artificial Tear) Forecast by Type
12.7 Global Eye Drops (Artificial Tear) Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Allergan
  13.1.1 Allergan Company Information
  13.1.2 Allergan Eye Drops (Artificial Tear) Product Offered
  13.1.3 Allergan Eye Drops (Artificial Tear) Sales, Revenue, Price and Gross Margin (2020-2022)
  13.1.4 Allergan Main Business Overview
  13.1.5 Allergan Latest Developments
13.2 Alcon
  13.2.1 Alcon Company Information
  13.2.2 Alcon Eye Drops (Artificial Tear) Product Offered
  13.2.3 Alcon Eye Drops (Artificial Tear) Sales, Revenue, Price and Gross Margin (2020-2022)
  13.2.4 Alcon Main Business Overview
  13.2.5 Alcon Latest Developments
13.3 Novartis
  13.3.1 Novartis Company Information
  13.3.2 Novartis Eye Drops (Artificial Tear) Product Offered
  13.3.3 Novartis Eye Drops (Artificial Tear) Sales, Revenue, Price and Gross Margin (2020-2022)
  13.3.4 Novartis Main Business Overview
  13.3.5 Novartis Latest Developments
13.4 Santen Pharma
  13.4.1 Santen Pharma Company Information
  13.4.2 Santen Pharma Eye Drops (Artificial Tear) Product Offered
  13.4.3 Santen Pharma Eye Drops (Artificial Tear) Sales, Revenue, Price and Gross Margin (2020-2022)
  13.4.4 Santen Pharma Main Business Overview
  13.4.5 Santen Pharma Latest Developments
13.5 Johnson & Johnson
  13.5.1 Johnson & Johnson Company Information
  13.5.2 Johnson & Johnson Eye Drops (Artificial Tear) Product Offered
  13.5.3 Johnson & Johnson Eye Drops (Artificial Tear) Sales, Revenue, Price and Gross Margin (2020-2022)
  13.5.4 Johnson & Johnson Main Business Overview
  13.5.5 Johnson & Johnson Latest Developments
13.6 Bausch & Lomb
  13.6.1 Bausch & Lomb Company Information
  13.6.2 Bausch & Lomb Eye Drops (Artificial Tear) Product Offered
  13.6.3 Bausch & Lomb Eye Drops (Artificial Tear) Sales, Revenue, Price and Gross Margin (2020-2022)
  13.6.4 Bausch & Lomb Main Business Overview
  13.6.5 Bausch & Lomb Latest Developments
13.7 Thea pharmaceuticals
  13.7.1 Thea pharmaceuticals Company Information
  13.7.2 Thea pharmaceuticals Eye Drops (Artificial Tear) Product Offered
  13.7.3 Thea pharmaceuticals Eye Drops (Artificial Tear) Sales, Revenue, Price and Gross Margin (2020-2022)
  13.7.4 Thea pharmaceuticals Main Business Overview
  13.7.5 Thea pharmaceuticals Latest Developments
13.8 URSAPHARM
  13.8.1 URSAPHARM Company Information
  13.8.2 URSAPHARM Eye Drops (Artificial Tear) Product Offered
  13.8.3 URSAPHARM Eye Drops (Artificial Tear) Sales, Revenue, Price and Gross Margin (2020-2022)
  13.8.4 URSAPHARM Main Business Overview
  13.8.5 URSAPHARM Latest Developments
13.9 SIMILASAN
  13.9.1 SIMILASAN Company Information
  13.9.2 SIMILASAN Eye Drops (Artificial Tear) Product Offered
  13.9.3 SIMILASAN Eye Drops (Artificial Tear) Sales, Revenue, Price and Gross Margin (2020-2022)
  13.9.4 SIMILASAN Main Business Overview
  13.9.5 SIMILASAN Latest Developments
13.10 Akorn
  13.10.1 Akorn Company Information
  13.10.2 Akorn Eye Drops (Artificial Tear) Product Offered
  13.10.3 Akorn Eye Drops (Artificial Tear) Sales, Revenue, Price and Gross Margin (2020-2022)
  13.10.4 Akorn Main Business Overview
  13.10.5 Akorn Latest Developments
13.11 United Laboratories
  13.11.1 United Laboratories Company Information
  13.11.2 United Laboratories Eye Drops (Artificial Tear) Product Offered
  13.11.3 United Laboratories Eye Drops (Artificial Tear) Sales, Revenue, Price and Gross Margin (2020-2022)
  13.11.4 United Laboratories Main Business Overview
  13.11.5 United Laboratories Latest Developments
13.12 Sun Pharmaceutical
  13.12.1 Sun Pharmaceutical Company Information
  13.12.2 Sun Pharmaceutical Eye Drops (Artificial Tear) Product Offered
  13.12.3 Sun Pharmaceutical Eye Drops (Artificial Tear) Sales, Revenue, Price and Gross Margin (2020-2022)
  13.12.4 Sun Pharmaceutical Main Business Overview
  13.12.5 Sun Pharmaceutical Latest Developments
13.13 Jianfeng Group
  13.13.1 Jianfeng Group Company Information
  13.13.2 Jianfeng Group Eye Drops (Artificial Tear) Product Offered
  13.13.3 Jianfeng Group Eye Drops (Artificial Tear) Sales, Revenue, Price and Gross Margin (2020-2022)
  13.13.4 Jianfeng Group Main Business Overview
  13.13.5 Jianfeng Group Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Eye Drops (Artificial Tear) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Eye Drops (Artificial Tear) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Allergy Eye Care
Table 4. Major Players of Standard Eye Care
Table 5. Global Eye Drops (Artificial Tear) Sales by Type (2017-2022) & (Tons)
Table 6. Global Eye Drops (Artificial Tear) Sales Market Share by Type (2017-2022)
Table 7. Global Eye Drops (Artificial Tear) Revenue by Type (2017-2022) & ($ million)
Table 8. Global Eye Drops (Artificial Tear) Revenue Market Share by Type (2017-2022)
Table 9. Global Eye Drops (Artificial Tear) Sale Price by Type (2017-2022) & (US$/Ton)
Table 10. Global Eye Drops (Artificial Tear) Sales by Application (2017-2022) & (Tons)
Table 11. Global Eye Drops (Artificial Tear) Sales Market Share by Application (2017-2022)
Table 12. Global Eye Drops (Artificial Tear) Revenue by Application (2017-2022)
Table 13. Global Eye Drops (Artificial Tear) Revenue Market Share by Application (2017-2022)
Table 14. Global Eye Drops (Artificial Tear) Sale Price by Application (2017-2022) & (US$/Ton)
Table 15. Global Eye Drops (Artificial Tear) Sales by Company (2020-2022) & (Tons)
Table 16. Global Eye Drops (Artificial Tear) Sales Market Share by Company (2020-2022)
Table 17. Global Eye Drops (Artificial Tear) Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Eye Drops (Artificial Tear) Revenue Market Share by Company (2020-2022)
Table 19. Global Eye Drops (Artificial Tear) Sale Price by Company (2020-2022) & (US$/Ton)
Table 20. Key Manufacturers Eye Drops (Artificial Tear) Producing Area Distribution and Sales Area
Table 21. Players Eye Drops (Artificial Tear) Products Offered
Table 22. Eye Drops (Artificial Tear) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Eye Drops (Artificial Tear) Sales by Geographic Region (2017-2022) & (Tons)
Table 26. Global Eye Drops (Artificial Tear) Sales Market Share Geographic Region (2017-2022)
Table 27. Global Eye Drops (Artificial Tear) Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Eye Drops (Artificial Tear) Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Eye Drops (Artificial Tear) Sales by Country/Region (2017-2022) & (Tons)
Table 30. Global Eye Drops (Artificial Tear) Sales Market Share by Country/Region (2017-2022)
Table 31. Global Eye Drops (Artificial Tear) Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Eye Drops (Artificial Tear) Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Eye Drops (Artificial Tear) Sales by Country (2017-2022) & (Tons)
Table 34. Americas Eye Drops (Artificial Tear) Sales Market Share by Country (2017-2022)
Table 35. Americas Eye Drops (Artificial Tear) Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Eye Drops (Artificial Tear) Revenue Market Share by Country (2017-2022)
Table 37. Americas Eye Drops (Artificial Tear) Sales by Type (2017-2022) & (Tons)
Table 38. Americas Eye Drops (Artificial Tear) Sales Market Share by Type (2017-2022)
Table 39. Americas Eye Drops (Artificial Tear) Sales by Application (2017-2022) & (Tons)
Table 40. Americas Eye Drops (Artificial Tear) Sales Market Share by Application (2017-2022)
Table 41. APAC Eye Drops (Artificial Tear) Sales by Region (2017-2022) & (Tons)
Table 42. APAC Eye Drops (Artificial Tear) Sales Market Share by Region (2017-2022)
Table 43. APAC Eye Drops (Artificial Tear) Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Eye Drops (Artificial Tear) Revenue Market Share by Region (2017-2022)
Table 45. APAC Eye Drops (Artificial Tear) Sales by Type (2017-2022) & (Tons)
Table 46. APAC Eye Drops (Artificial Tear) Sales Market Share by Type (2017-2022)
Table 47. APAC Eye Drops (Artificial Tear) Sales by Application (2017-2022) & (Tons)
Table 48. APAC Eye Drops (Artificial Tear) Sales Market Share by Application (2017-2022)
Table 49. Europe Eye Drops (Artificial Tear) Sales by Country (2017-2022) & (Tons)
Table 50. Europe Eye Drops (Artificial Tear) Sales Market Share by Country (2017-2022)
Table 51. Europe Eye Drops (Artificial Tear) Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Eye Drops (Artificial Tear) Revenue Market Share by Country (2017-2022)
Table 53. Europe Eye Drops (Artificial Tear) Sales by Type (2017-2022) & (Tons)
Table 54. Europe Eye Drops (Artificial Tear) Sales Market Share by Type (2017-2022)
Table 55. Europe Eye Drops (Artificial Tear) Sales by Application (2017-2022) & (Tons)
Table 56. Europe Eye Drops (Artificial Tear) Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Eye Drops (Artificial Tear) Sales by Country (2017-2022) & (Tons)
Table 58. Middle East & Africa Eye Drops (Artificial Tear) Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Eye Drops (Artificial Tear) Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Eye Drops (Artificial Tear) Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Eye Drops (Artificial Tear) Sales by Type (2017-2022) & (Tons)
Table 62. Middle East & Africa Eye Drops (Artificial Tear) Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Eye Drops (Artificial Tear) Sales by Application (2017-2022) & (Tons)
Table 64. Middle East & Africa Eye Drops (Artificial Tear) Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Eye Drops (Artificial Tear)
Table 66. Key Market Challenges & Risks of Eye Drops (Artificial Tear)
Table 67. Key Industry Trends of Eye Drops (Artificial Tear)
Table 68. Eye Drops (Artificial Tear) Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Eye Drops (Artificial Tear) Distributors List
Table 71. Eye Drops (Artificial Tear) Customer List
Table 72. Global Eye Drops (Artificial Tear) Sales Forecast by Region (2023-2028) & (Tons)
Table 73. Global Eye Drops (Artificial Tear) Sales Market Forecast by Region
Table 74. Global Eye Drops (Artificial Tear) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Eye Drops (Artificial Tear) Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Eye Drops (Artificial Tear) Sales Forecast by Country (2023-2028) & (Tons)
Table 77. Americas Eye Drops (Artificial Tear) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Eye Drops (Artificial Tear) Sales Forecast by Region (2023-2028) & (Tons)
Table 79. APAC Eye Drops (Artificial Tear) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Eye Drops (Artificial Tear) Sales Forecast by Country (2023-2028) & (Tons)
Table 81. Europe Eye Drops (Artificial Tear) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Eye Drops (Artificial Tear) Sales Forecast by Country (2023-2028) & (Tons)
Table 83. Middle East & Africa Eye Drops (Artificial Tear) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Eye Drops (Artificial Tear) Sales Forecast by Type (2023-2028) & (Tons)
Table 85. Global Eye Drops (Artificial Tear) Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Eye Drops (Artificial Tear) Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Eye Drops (Artificial Tear) Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Eye Drops (Artificial Tear) Sales Forecast by Application (2023-2028) & (Tons)
Table 89. Global Eye Drops (Artificial Tear) Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Eye Drops (Artificial Tear) Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Eye Drops (Artificial Tear) Revenue Market Share Forecast by Application (2023-2028)
Table 92. Allergan Basic Information, Eye Drops (Artificial Tear) Manufacturing Base, Sales Area and Its Competitors
Table 93. Allergan Eye Drops (Artificial Tear) Product Offered
Table 94. Allergan Eye Drops (Artificial Tear) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 95. Allergan Main Business
Table 96. Allergan Latest Developments
Table 97. Alcon Basic Information, Eye Drops (Artificial Tear) Manufacturing Base, Sales Area and Its Competitors
Table 98. Alcon Eye Drops (Artificial Tear) Product Offered
Table 99. Alcon Eye Drops (Artificial Tear) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 100. Alcon Main Business
Table 101. Alcon Latest Developments
Table 102. Novartis Basic Information, Eye Drops (Artificial Tear) Manufacturing Base, Sales Area and Its Competitors
Table 103. Novartis Eye Drops (Artificial Tear) Product Offered
Table 104. Novartis Eye Drops (Artificial Tear) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 105. Novartis Main Business
Table 106. Novartis Latest Developments
Table 107. Santen Pharma Basic Information, Eye Drops (Artificial Tear) Manufacturing Base, Sales Area and Its Competitors
Table 108. Santen Pharma Eye Drops (Artificial Tear) Product Offered
Table 109. Santen Pharma Eye Drops (Artificial Tear) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 110. Santen Pharma Main Business
Table 111. Santen Pharma Latest Developments
Table 112. Johnson & Johnson Basic Information, Eye Drops (Artificial Tear) Manufacturing Base, Sales Area and Its Competitors
Table 113. Johnson & Johnson Eye Drops (Artificial Tear) Product Offered
Table 114. Johnson & Johnson Eye Drops (Artificial Tear) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 115. Johnson & Johnson Main Business
Table 116. Johnson & Johnson Latest Developments
Table 117. Bausch & Lomb Basic Information, Eye Drops (Artificial Tear) Manufacturing Base, Sales Area and Its Competitors
Table 118. Bausch & Lomb Eye Drops (Artificial Tear) Product Offered
Table 119. Bausch & Lomb Eye Drops (Artificial Tear) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 120. Bausch & Lomb Main Business
Table 121. Bausch & Lomb Latest Developments
Table 122. Thea pharmaceuticals Basic Information, Eye Drops (Artificial Tear) Manufacturing Base, Sales Area and Its Competitors
Table 123. Thea pharmaceuticals Eye Drops (Artificial Tear) Product Offered
Table 124. Thea pharmaceuticals Eye Drops (Artificial Tear) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 125. Thea pharmaceuticals Main Business
Table 126. Thea pharmaceuticals Latest Developments
Table 127. URSAPHARM Basic Information, Eye Drops (Artificial Tear) Manufacturing Base, Sales Area and Its Competitors
Table 128. URSAPHARM Eye Drops (Artificial Tear) Product Offered
Table 129. URSAPHARM Eye Drops (Artificial Tear) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 130. URSAPHARM Main Business
Table 131. URSAPHARM Latest Developments
Table 132. SIMILASAN Basic Information, Eye Drops (Artificial Tear) Manufacturing Base, Sales Area and Its Competitors
Table 133. SIMILASAN Eye Drops (Artificial Tear) Product Offered
Table 134. SIMILASAN Eye Drops (Artificial Tear) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 135. SIMILASAN Main Business
Table 136. SIMILASAN Latest Developments
Table 137. Akorn Basic Information, Eye Drops (Artificial Tear) Manufacturing Base, Sales Area and Its Competitors
Table 138. Akorn Eye Drops (Artificial Tear) Product Offered
Table 139. Akorn Eye Drops (Artificial Tear) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 140. Akorn Main Business
Table 141. Akorn Latest Developments
Table 142. United Laboratories Basic Information, Eye Drops (Artificial Tear) Manufacturing Base, Sales Area and Its Competitors
Table 143. United Laboratories Eye Drops (Artificial Tear) Product Offered
Table 144. United Laboratories Eye Drops (Artificial Tear) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 145. United Laboratories Main Business
Table 146. United Laboratories Latest Developments
Table 147. Sun Pharmaceutical Basic Information, Eye Drops (Artificial Tear) Manufacturing Base, Sales Area and Its Competitors
Table 148. Sun Pharmaceutical Eye Drops (Artificial Tear) Product Offered
Table 149. Sun Pharmaceutical Eye Drops (Artificial Tear) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 150. Sun Pharmaceutical Main Business
Table 151. Sun Pharmaceutical Latest Developments
Table 152. Jianfeng Group Basic Information, Eye Drops (Artificial Tear) Manufacturing Base, Sales Area and Its Competitors
Table 153. Jianfeng Group Eye Drops (Artificial Tear) Product Offered
Table 154. Jianfeng Group Eye Drops (Artificial Tear) Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 155. Jianfeng Group Main Business
Table 156. Jianfeng Group Latest Developments

LIST OF FIGURES

Figure 1. Picture of Eye Drops (Artificial Tear)
Figure 2. Eye Drops (Artificial Tear) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Eye Drops (Artificial Tear) Sales Growth Rate 2017-2028 (Tons)
Figure 7. Global Eye Drops (Artificial Tear) Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Eye Drops (Artificial Tear) Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Allergy Eye Care
Figure 10. Product Picture of Standard Eye Care
Figure 11. Global Eye Drops (Artificial Tear) Sales Market Share by Type in 2021
Figure 12. Global Eye Drops (Artificial Tear) Revenue Market Share by Type (2017-2022)
Figure 13. Eye Drops (Artificial Tear) Consumed in Pharmacy
Figure 14. Global Eye Drops (Artificial Tear) Market: Pharmacy (2017-2022) & (Tons)
Figure 15. Eye Drops (Artificial Tear) Consumed in Internet
Figure 16. Global Eye Drops (Artificial Tear) Market: Internet (2017-2022) & (Tons)
Figure 17. Eye Drops (Artificial Tear) Consumed in Grocery
Figure 18. Global Eye Drops (Artificial Tear) Market: Grocery (2017-2022) & (Tons)
Figure 19. Eye Drops (Artificial Tear) Consumed in Optical Chains
Figure 20. Global Eye Drops (Artificial Tear) Market: Optical Chains (2017-2022) & (Tons)
Figure 21. Global Eye Drops (Artificial Tear) Sales Market Share by Application (2017-2022)
Figure 22. Global Eye Drops (Artificial Tear) Revenue Market Share by Application in 2021
Figure 23. Eye Drops (Artificial Tear) Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Eye Drops (Artificial Tear) Revenue Market Share by Company in 2021
Figure 25. Global Eye Drops (Artificial Tear) Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Eye Drops (Artificial Tear) Revenue Market Share by Geographic Region in 2021
Figure 27. Global Eye Drops (Artificial Tear) Sales Market Share by Region (2017-2022)
Figure 28. Global Eye Drops (Artificial Tear) Revenue Market Share by Country/Region in 2021
Figure 29. Americas Eye Drops (Artificial Tear) Sales 2017-2022 (Tons)
Figure 30. Americas Eye Drops (Artificial Tear) Revenue 2017-2022 ($ Millions)
Figure 31. APAC Eye Drops (Artificial Tear) Sales 2017-2022 (Tons)
Figure 32. APAC Eye Drops (Artificial Tear) Revenue 2017-2022 ($ Millions)
Figure 33. Europe Eye Drops (Artificial Tear) Sales 2017-2022 (Tons)
Figure 34. Europe Eye Drops (Artificial Tear) Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Eye Drops (Artificial Tear) Sales 2017-2022 (Tons)
Figure 36. Middle East & Africa Eye Drops (Artificial Tear) Revenue 2017-2022 ($ Millions)
Figure 37. Americas Eye Drops (Artificial Tear) Sales Market Share by Country in 2021
Figure 38. Americas Eye Drops (Artificial Tear) Revenue Market Share by Country in 2021
Figure 39. United States Eye Drops (Artificial Tear) Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Eye Drops (Artificial Tear) Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Eye Drops (Artificial Tear) Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Eye Drops (Artificial Tear) Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Eye Drops (Artificial Tear) Sales Market Share by Region in 2021
Figure 44. APAC Eye Drops (Artificial Tear) Revenue Market Share by Regions in 2021
Figure 45. China Eye Drops (Artificial Tear) Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Eye Drops (Artificial Tear) Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Eye Drops (Artificial Tear) Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Eye Drops (Artificial Tear) Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Eye Drops (Artificial Tear) Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Eye Drops (Artificial Tear) Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Eye Drops (Artificial Tear) Sales Market Share by Country in 2021
Figure 52. Europe Eye Drops (Artificial Tear) Revenue Market Share by Country in 2021
Figure 53. Germany Eye Drops (Artificial Tear) Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Eye Drops (Artificial Tear) Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Eye Drops (Artificial Tear) Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Eye Drops (Artificial Tear) Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Eye Drops (Artificial Tear) Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Eye Drops (Artificial Tear) Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Eye Drops (Artificial Tear) Revenue Market Share by Country in 2021
Figure 60. Egypt Eye Drops (Artificial Tear) Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Eye Drops (Artificial Tear) Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Eye Drops (Artificial Tear) Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Eye Drops (Artificial Tear) Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Eye Drops (Artificial Tear) Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Eye Drops (Artificial Tear) in 2021
Figure 66. Manufacturing Process Analysis of Eye Drops (Artificial Tear)
Figure 67. Industry Chain Structure of Eye Drops (Artificial Tear)
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles


More Publications